Key regions: Germany, United States, India, Japan, United Kingdom
The demand for Anti-Rheumatic Drugs in Ethiopia has been on the rise in recent years.
Customer preferences: Patients in Ethiopia suffering from rheumatic diseases prefer to use Anti-Rheumatic Drugs due to their effectiveness in reducing inflammation and pain. The drugs are also readily available in local pharmacies and hospitals.
Trends in the market: The Anti-Rheumatic Drugs market in Ethiopia has been growing steadily due to an increase in the prevalence of rheumatic diseases. The market is expected to continue growing as the population ages and the incidence of rheumatic diseases increases. Additionally, the government's efforts to improve healthcare access and infrastructure have led to more patients seeking treatment for rheumatic diseases.
Local special circumstances: Ethiopia has a high prevalence of rheumatic diseases, with a significant portion of the population suffering from conditions such as rheumatoid arthritis and osteoarthritis. The lack of access to preventive healthcare and poor living conditions contribute to the high incidence of these diseases. Additionally, traditional medicine is still widely used in Ethiopia, which can lead to delays in seeking modern medical treatment.
Underlying macroeconomic factors: The Ethiopian economy has been growing steadily in recent years, with a focus on developing the healthcare sector. The government has increased healthcare spending and implemented policies to improve healthcare access and infrastructure. This has led to an increase in the availability and affordability of Anti-Rheumatic Drugs in the country. However, the high cost of importing these drugs can still be a barrier to access for some patients.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
